Interobserver concordance in visual assessment of Ki67 immunohistochemistry in surgical excision specimens from patients with lymph node-negative breast cancer

被引：0
作者：
Susanna Thomas
Masrura Kabir
Belinda E. Butcher
Shaun Chou
Hema Mahajan
Gelareh Farshid
Rosemary Balleine
Nirmala Pathmanathan
机构：
[1] Westmead Breast Cancer Institute,School of Medical Sciences
[2] Western Sydney Local Health District,Institute of Clinical Pathology and Medical Research, Pathology West
[3] Australian Clinical Labs,Westmead Clinical School
[4] WriteSource Medical Pty Ltd,School of Medical Sciences
[5] University of New South Wales,Faculty of Medicine and Health
[6] NSW Health Pathology,undefined
[7] University of Sydney,undefined
[8] SA Pathology,undefined
[9] Royal Adelaide Hospital,undefined
[10] University of Adelaide,undefined
[11] Children’s Medical Research Institute,undefined
[12] University of Sydney,undefined
[13] Douglass Hanly Moir Pathology,undefined
来源：
Breast Cancer Research and Treatment | 2021年 / 188卷
关键词：
Ki67; Proliferation; Breast cancer; Interobserver variability;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：729 / 737
页数：8
相关论文
共 117 条
  • [21] Fasching K(2012)Ki-67: level of evidence and methodological considerations for its role in the clinical management of breast cancer: analytical and critical review Breast Cancer Res Treat 132 895-2826
  • [22] Heusinger L(2013)Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer Ann Oncol 24 2206-681
  • [23] Haeberle MY(2013)Long-term prognostic performance of Ki67 rate in early stage, pT1-pT2, pN0, invasive breast carcinoma PLoS ONE 8 e55901-235
  • [24] Polley SC(1991)Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 403-undefined
  • [25] Leung LM(2020)Do YOU know the Ki-67 index of your breast cancer patients? Knowledge of your institution’s Ki-67 index distribution and its robustness is essential for decision-making in early breast cancer Breast 51 120-undefined
  • [26] McShane SC(2004)A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer N Engl J Med 351 2817-undefined
  • [27] Leung TO(2004)Prognostic value of proliferation in invasive breast cancer: a review J Clin Pathol 57 675-undefined
  • [28] Nielsen L(2019)Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration Histopathology 75 225-undefined
  • [29] Zabaglo I(undefined)undefined undefined undefined undefined-undefined
  • [30] Arun SS(undefined)undefined undefined undefined undefined-undefined
12345678910